Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 14158-14171

  Shin, Dong Yeok ^a   Kim, Gi Young ^b   Lee, Jun Hyuk ^c   Choi, Byung Tae ^d   Yoo, Young Hyun ^e   Choi, Yung Hyun ^f  

^a Dongnam Institute of Radiological and Medical Science   (South Korea)

^b Jeju National University   (South Korea)

^c Korea Intellectual Property Office   (South Korea)

^d Pusan National University   (South Korea)

^e Dong A University   (South Korea)

^f Dong Eui University   (South Korea)

Author keywords

Apoptosis; Diallyl disulfide; MAPK; PI3K Akt

Indexed keywords

CASPASE; DEATH RECEPTOR 4; DIALLYL DISULFIDE; FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; ALLYL COMPOUND; APOPTOSIS REGULATORY PROTEIN; DISULFIDE; MATRIX METALLOPROTEINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ALLYL COMPOUNDS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DISULFIDES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MATRIX METALLOPROTEINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84870720211     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131114158     Document Type: Article

References (42)

1. Block, G.; Jensen, C.D.; Norkus, E.P.; Dalvi, T.B.; Wong, L.G.; McManus, J.F.; Hudes, M.L. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: A cross-sectional study. Nutr. J. 2007, 6, 30.
2. Bose, C.; Guo, J.; Zimniak, L.; Srivastava, S.K.; Singh, S.P.; Zimniak, P.; Singh, S.V. Critical role of allyl groups and disulfide chain in induction of Pi class glutathione transferase in mouse tissues in vivo by diallyl disulfide, a naturally occurring chemopreventive agent in garlic. Carcinogenesis 2002, 23, 1661-1665.
3. Swiderski, F.; Dabrowska, M.; Rusaczonek, A.; Waszkiewicz-Robak, B. Bioactive substances of garlic and their role in dietoprophylaxis and dietotherapy. Rocz. Panstw. Zakl. Hig. 2007, 58, 41-46.
4. Iciek, M.; Kwiecień, I.; Włodek, L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ. Mol. Mutagen. 2009, 50, 247-265.
5. Gayathri, R.; Gunadharini, D.N.; Arunkumar, A.; Senthilkumar, K.; Krishnamoorthy, G.; Banudevi, S.; Vignesh, R.C.; Arunakaran, J. Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3). Mol. Cell Biochem. 2009, 320, 197-203.
6. Aggarwal, B.B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71, 1397-1421.
7. Nagini, S. Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise? Anticancer Agents Med. Chem. 2008, 8, 313-321.
8. Kaschula, C.H.; Hunter, R.; Parker, M.I. Garlic-derived anticancer agents: Structure and biological activity of ajoene. Biofactors 2010, 36, 78-85.
9. Antony, M.L.; Singh, S.V. Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide. Indian J. Exp. Biol. 2011, 49, 805-816.
10. Bautista, D.M.; Movahed, P.; Hinman, A.; Axelsson, H.E.; Sterner, O.; Högestätt, E.D.; Julius, D.; Jordt, S.E.; Zygmunt, P.M. Pungent products from garlic activate the sensory ion channel TRPA1. Proc. Natl. Acad. Sci. USA 2005, 102, 12248-12252.
11. Shin, D.Y.; Kim, G.Y.; Kim, J.I.; Yoon, M.K.; Kwon, T.K.; Lee, S.J.; Choi, Y.W.; Kang, H.S.; Yoo, Y.H.; Choi, Y.H. Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells. Toxicol. In Vitro 2010, 24, 1569-1576.
12. Tsubura, A.; Lai, Y.C.; Kuwata, M.; Uehara, N.; Yoshizawa, K. Anticancer effects of garlic and garlic-derived compounds for breast cancer control. Anticancer Agents Med. Chem. 2011, 11, 249-253.
13. Park, H.S.; Kim, G.Y.; Choi, I.W.; Kim, N.D.; Hwang, H.J.; Choi, Y.W.; Choi, Y.H. Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells. J. Food Sci. 2011, 76, T105-T111.
14. Park, H.Y.; Kim, N.D.; Kim, G.Y.; Hwang, H.J.; Kim, B.W.; Kim, W.J.; Choi, Y.H. Inhibitory effects of diallyl disulfide on the production of inflammatory mediators and cytokines in lipopolysaccharide-activated BV2 microglia. Toxicol. Appl. Pharmacol. 2012, 262, 177-184.
15. Sundaram, S.G.; Milner, J.A. Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J. Nutr. 1996, 126, 1355-1361.
16. Tan, H.; Ling, H.; He, J.; Yi, L.; Zhou, J.; Lin, M.; Su, Q. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells. Arch. Pharm. Res. 2008, 31, 786-793.
17. Wen, J.; Zhang, Y.; Chen, X.; Shen, L.; Li, G.C.; Xu, M. Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. Biochem. Pharmacol. 2004, 68, 323-331.
18. Kwon, K.B.; Yoo, S.J.; Ryu, D.G.; Yang, J.Y.; Rho, H.W.; Kim, J.S.; Park, J.W.; Kim, H.R.; Park, B.H. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol. 2002, 63, 41-47.
19. Bottone, F.G., Jr.; Baek, S.J.; Nixon, J.B.; Eling, T.E. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr. 2002, 132, 773-778.
20. Filomeni, G.; Aquilano, K.; Rotilio, G.; Ciriolo, M.R. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res. 2003, 63, 5940-5949.
21. Arunkumar, A.; Vijayababu, M.R.; Gunadharini, N.; Krishnamoorthy, G.; Arunakaran, J. Induction of apoptosis and histone hyperacetylation by diallyl disulfide in prostate cancer cell line PC-3. Cancer Lett. 2007, 251, 59-67.
22. Xiao, D.; Choi, S.; Johnson, D.E.; Vogel, V.G.; Johnson, C.S.; Trump, D.L.; Lee, Y.J.; Singh, S.V. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004, 23, 5594-5606.
23. Kroemer, G.; Reed, J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6, 513-519.
24. Jin, Z.; El-Deiry, W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 2005, 4, 139-163.
25. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
26. Fulda, S.; Debatin, K.M. Targeting inhibitor of apoptosis proteins (IAPs) for diagnosis and treatment of human diseases. Recent Pat. Anticancer Drug Discov. 2006, 1, 81-89.
27. Ashkenazi, A.; Holland, P.; Eckhardt, S.G. Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J. Clin. Oncol. 2008, 26, 3621-3630.
28. Röder, C.; Trauzold, A.; Kalthoff, H. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma. Eur. J. Cell Biol. 2011, 90, 450-455.
29. Scaffidi, C.; Schmitz, I.; Zha, J.; Korsmeyer, S.J.; Krammer, P.H.; Peter, M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 1999, 274, 22532-22538.
30. Lawen, A. Apoptosis-an introduction. Bioessays 2003, 25, 888-896.
31. Brenner, D.; Mak, T.W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 2009, 21, 871-877.
32. Li, H.; Zhu, H.; Xu, C.J.; Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94, 491-501.
33. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94, 481-490.
34. Lazebnik, Y.A.; Kaufmann, S.H.; Desnoyers, S.; Poirier, G.G.; Earnshaw, W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371, 346-347.
35. Fukuda, K. Apoptosis-associated cleavage of β-catenin in human colon cancer and rat hepatoma cells. Int. J. Biochem. Cell Biol. 1999, 31, 519-529.
36. Danson, S.; Dean, E.; Dive, C.; Ranson, M. IAPs as a target for anticancer therapy. Curr. Cancer Drug Targets 2007, 7, 785-794.
37. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R.J.; Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331.
38. Boutros, T.; Chevet, E.; Metrakos, P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol. Rev. 2008, 60, 261-310.
39. Barragan, M.; Bellosillo, B.; Campas, C.; Colomer, D.; Pons, G.; Gil, J. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 2002, 99, 2969-2976.
40. Zhang, X.; Jin, B.; Huang, C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr. Cancer Drug Targets 2007, 7, 305-316.
41. Tak, J.K.; Lee, J.H.; Park, J.W. Resveratrol and piperine enhance radiosensitivity of tumor cells. BMB Rep. 2012, 45, 242-246.
42. Wang, M.F.; Liao, Y.F.; Hung, Y.C.; Lin, C.L.; Hour, T.C.; Lue, K.H.; Hung, H.C.; Liu, G.Y. Hydroxydibenzoylmethane induces apoptosis through repressing ornithine decarboxylase in human promyelocytic leukemia HL-60 cells. Exp. Mol. Med. 2011, 43, 189-196.